Ligne de temps
Laura Schaeffer
Ingénieur(e) de Recherche
20 août 2025
08 juin 2025
06 juin 2025
project
Vax-Action – MINT & SMART (Motivational Interviewing Training & Short Mapping And Reflexivity Tool) : Développement et évaluation d’interventions pour favoriser l’acceptation vaccinale à destination des professionnels de santé
Lire plus05 juin 2025
project
MAGFA – Dosage immunologique magnétique au point de service pour l’Afrique subsaharienne : Application à la triple élimination de la transmission mère-enfant du VIH, des hépatites virales et de la syphilis
Lire plus17 mars 2025
news
Hépatite B : une nouvelle méthode de détection rapide du virus pour limiter la transmission mère-enfant
Lire plus12 mars 2025
publication
Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study.
Lire plus13 nov. 2024
18 oct. 2024
05 sept. 2023
publication
Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022.
Lire plus23 août 2023
publication
Molecular Detection of Orthohantavirus puumalaense in Plasma and Urine Samples from Hospitalized Patients Presenting with a Serologically Confirmed Acute Hantavirus Infection in France.
Lire plus01 juin 2023
01 juin 2023
publication
SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study.
Lire plus01 mai 2023
publication
SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022.
Lire plus01 févr. 2022
publication
Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.
Lire plus01 sept. 2021
publication
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.
Lire plus01 août 2021
publication
Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study.
Lire plus30 juil. 2021
publication
Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Lire plus01 juin 2021
publication
Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).
Lire plus04 mai 2021
project
ComCor: Study of sociodemographic factors, behaviors and practices associated with SARS-CoV-2 infection
Lire plus17 mars 2020
publication
Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients.
Lire plus14 sept. 2015
project
ANRS 12332 HepNile: Evaluation of “Real Life” Efficacy and Safety of antiviral treatments including new Direct Antiviral Agents among patients treated for Chronic Hepatitis C at Egyptian National Treatment Centres
Lire plus11 mai 2015